VIHUMA

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug VIHUMA contains one active pharmaceutical ingredient (API):

1 Coagulation factor VIII UNII U50VWW6XH6 - SIMOCTOCOG ALFA

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies. Read about Coagulation factor VIII

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIHUMA Powder and solvent for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1739145, 1739156, 1739167, 1739178, 1787216, 1787227, 1787238
Country: IT	Agenzia del Farmaco	Identifier(s): 045273012, 045273024, 045273036, 045273048, 045273051, 045273063, 045273075
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1082394, 1082395, 1082396, 1082397, 1086901, 1086902, 1086903
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100387600, 100387616, 100387622, 100387639, 100417197, 100417205, 100417211